Mackenzie Financial Corp Bausch Health Companies Inc. Transaction History

Mackenzie Financial Corp

$71.6 Billion
Q2 2025

A detailed history of Mackenzie Financial Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 212,293 shares of BHC stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,293

Previous 202,616 4.78%

Holding current value

$1.49 Million

Previous $1.31 Million 7.86%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$4.32 - $6.66 $41,804 - $64,448	9,677 Added 4.78%	212,293 $1.41 Million
Q1 2025 May 07, 2025	SELL	$6.16 - $7.94 $33,818 - $43,590	-5,490 Reduced 2.64%	202,616 $1.31 Million
Q4 2024 Feb 14, 2025	BUY	$7.34 - $9.78 $48,377 - $64,459	6,591 Added 3.27%	208,106 $1.68 Million
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $11.4 Million - $18 Million	-2,180,373 Reduced 91.54%	201,515 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $7.64 Million - $13 Million	1,252,834 Added 110.96%	2,381,888 $16.6 Million
Q1 2024 May 10, 2024	SELL	$7.77 - $10.61 $3.37 Million - $4.6 Million	-433,640 Reduced 27.75%	1,129,054 $12 Million
Q4 2023 Jan 30, 2024	BUY	$6.53 - $8.23 $2.16 Million - $2.73 Million	331,462 Added 26.92%	1,562,694 $12.5 Million
Q3 2023 Oct 25, 2023	BUY	$7.69 - $9.71 $711,440 - $898,320	92,515 Added 8.12%	1,231,232 $10.1 Million
Q2 2023 Aug 03, 2023	BUY	$5.72 - $8.8 $261,792 - $402,758	45,768 Added 4.19%	1,138,717 $9.11 Million
Q1 2023 Apr 24, 2023	SELL	$6.28 - $9.85 $559,321 - $877,280	-89,064 Reduced 7.53%	1,092,949 $8.85 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $1.17 Million - $1.52 Million	-192,043 Reduced 13.98%	1,182,013 $7.42 Million
Q3 2022 Oct 07, 2022	BUY	$4.58 - $9.21 $2.92 Million - $5.86 Million	636,607 Added 86.33%	1,374,056 $9.48 Million
Q2 2022 Aug 10, 2022	BUY	$7.06 - $23.63 $2.34 Million - $7.83 Million	331,349 Added 81.59%	737,449 $6.17 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $1.04 Million - $1.34 Million	48,185 Added 13.46%	406,100 $9.29 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $3.24 Million - $4.09 Million	140,983 Added 64.99%	357,915 $9.89 Million
Q3 2021 Nov 08, 2021	SELL	$25.04 - $30.06 $85,711 - $102,895	-3,423 Reduced 1.55%	216,932 $6.04 Million
Q2 2021 Aug 11, 2021	SELL	$27.43 - $32.7 $236,199 - $281,579	-8,611 Reduced 3.76%	220,355 $6.46 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $2.56 Million - $4.13 Million	119,985 Added 110.1%	228,966 $7.26 Million
Q4 2020 Feb 10, 2021	SELL	$15.31 - $21.12 $623,316 - $859,858	-40,713 Reduced 27.2%	108,981 $2.25 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $578,732 - $891,795	-43,481 Reduced 22.51%	149,694 $2.74 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $1.6 Million - $3.73 Million	123,228 Added 176.17%	193,175 $2.99 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $158,505 - $267,588	8,391 Added 13.63%	69,947 $2.1 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $725,851 - $892,018	-34,763 Reduced 36.09%	61,556 $1.35 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $3.34 Million - $4.3 Million	-162,699 Reduced 62.81%	96,319 $2.43 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $422,301 - $548,803	20,875 Added 8.77%	259,018 $6.4 Million
Q4 2018 Feb 06, 2019	SELL	$17.64 - $28.32 $19,668 - $31,576	-1,115 Reduced 0.47%	238,143 $4.4 Million
Q3 2018 Nov 15, 2018	BUY	$20.64 - $25.67 $4.94 Million - $6.14 Million	239,258 New	239,258 $6.14 Million

Others Institutions Holding BHC

# of Institutions

253

Shares Held

240M

Call Options Held

2.46M

Put Options Held

8.42M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.54B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Bausch Health Companies Inc. Transaction History